STAT3 does not regulate acute liver injury after ischemia/reperfusion

Area of Science:

• Hepatology
• Immunology
• Molecular Biology

Background:

• Hepatic ischemia/reperfusion (I/R) injury is a significant complication in liver surgery and transplantation.
• Interleukin-6 (IL-6) negatively regulates acute inflammatory injury post-hepatic I/R.
• Signal transducer and activator of transcription-3 (STAT3), a target of IL-6, is implicated in liver preconditioning but its role in acute I/R injury is unclear.

Purpose of the Study:

• To investigate the role of STAT3 phosphorylation in regulating acute inflammatory liver injury following hepatic I/R.
• To determine if blocking STAT3 activation impacts the severity of liver injury induced by I/R.

Main Methods:

• Male Balb/c mice underwent 90 minutes of partial hepatic ischemia followed by reperfusion.
• Mice were treated with STAT3 inhibitors AG490 (JAK2 inhibitor) or STATTIC (direct STAT3 phosphorylation inhibitor).
• Liver injury and neutrophil accumulation were assessed 8 and 24 hours post-reperfusion.

Main Results:

• Hepatic I/R induced STAT3 activation, which was inhibited by AG490 and STATTIC.
• Neither inhibitor altered the extent of acute liver injury.
• STATTIC treatment reduced hepatic neutrophil accumulation, but not overall liver injury.

Conclusions:

• STAT3 activation is induced by hepatic I/R but does not appear to be a central regulator of acute liver injury.
• Inhibition of STAT3 phosphorylation does not protect against I/R-induced liver damage.
• STAT3 may play a role in modulating neutrophil infiltration rather than direct injury regulation.